Circulating adiponectin concentrations are decreased in obese [3] and type 2 diabetes [4] and the reduction is believed to have a role in the pathogenesis of cardiovascular diseases associated with obesity and other components of the metabolic syndrome [5-7]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.